Managing moderate to severe acne in adolescents: Benefits of a fixed combination clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in a subpopulation of 1755 subjects

被引:0
|
作者
Cook-Bolden, Fran
Chen, Diana [1 ]
Eichenfield, Lawrence [2 ]
Stein-Gold, Linda [3 ]
机构
[1] Arcutis Pharmaceut Inc, Redwood City, CA USA
[2] Rady Childrens Hosp, San Diego, CA USA
[3] Henry Ford Med Ctr, Detroit, MI USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:AB22 / AB22
页数:1
相关论文
共 49 条
  • [21] Efficacy and safety of fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel in Hispanic participants with moderate-to-severe acne: a pooled analysis
    Callender, Valerie D.
    Baldwin, Hilary
    Gold, Linda Stein
    Cook-Bolden, Fran E.
    Guenin, Eric
    Alexis, Andrew F.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
  • [22] Treatment of acne and acne-related scarring with fixed combination clindamycin phosphate and benzoyl peroxide gel (1.2%/3.75%) and tretinoin gel microsphere 0.06% in an Asian American transgender female
    Kaminska, Edidiong C. N.
    SAGE OPEN MEDICAL CASE REPORTS, 2020, 8
  • [23] Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel
    Harper, Julie C.
    Kircik, Leon
    Gold, Michael
    Hebert, Adelaide A.
    Sugarman, Jeffrey L.
    Green, Lawrence
    Gold, Linda Stein
    Baldwin, Hilary
    Guenin, Eric
    Del Rosso, James
    JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (03) : 125 - 131
  • [24] Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug
    Stein Gold, Linda
    Baldwin, Hilary
    Kircik, Leon H.
    Weiss, Jonathan S.
    Pariser, David M.
    Callender, Valerie
    Lain, Edward
    Gold, Michael
    Beer, Kenneth
    Draelos, Zoe
    Sadick, Neil
    Pillai, Radhakrishnan
    Bhatt, Varsha
    Tanghetti, Emil A.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (01) : 93 - 104
  • [25] Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug
    Linda Stein Gold
    Hilary Baldwin
    Leon H. Kircik
    Jonathan S. Weiss
    David M. Pariser
    Valerie Callender
    Edward Lain
    Michael Gold
    Kenneth Beer
    Zoe Draelos
    Neil Sadick
    Radhakrishnan Pillai
    Varsha Bhatt
    Emil A. Tanghetti
    American Journal of Clinical Dermatology, 2022, 23 : 93 - 104
  • [26] The Efficacy and Tolerability of a Fixed Combination Clindamycin (1.2%) and Benzoyl Peroxide (3.75%) Aqueous Gel in Patients With Facial Acne Vulgaris: Gender as a Clinically Relevant Outcome Variable
    Harper, Julie C.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (04) : 381 - 384
  • [27] When Do Efficacy Outcomes in Clinical Trials Correlate With Clinical Relevance? Analysis of Clindamycin Phosphate 1.2%-Benzoyl Peroxide 3.75% Gel in Moderate to Severe Acne Vulgaris
    Del Rosso, James Q.
    CUTIS, 2016, 98 (01): : 21 - 25
  • [28] BUDGET IMPACT ANALYSIS OF A TRIPLE-AGENT FIXED-DOSE COMBINATION OF 1.2% CLINDAMYCIN PHOSPHATE, 0.15% ADAPALENE, AND 3.1% BENZOYL PEROXIDE TOPICAL GEL FOR THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE ACNE VULGARIS IN THE US
    Thomas, A.
    Harper, J.
    Soni, P.
    Dey, D.
    Bhattacharyya, S.
    Cohen, B.
    Lin, T.
    Olujohungbe, O.
    Samson, A.
    Bumpass, B.
    Jospeh, G.
    Dashputre, A.
    VALUE IN HEALTH, 2024, 27 (06) : S59 - S59
  • [29] Fixed-Combination Monotherapy With Clindamycin 1%-Benzoyl Peroxide 5% Gel: FOCUS ON ACNE PATIENT BENEFITS AND CLINICAL USE Introduction
    Eichenfield, Lawrence
    CUTIS, 2009, 84 (05): : 3 - 4
  • [30] Efficacy and Safety of Tretinoin 0.025%/Clindamycin Phosphate 1.2% Gel in Combination With Benzoyl Peroxide 6% Cleansing Cloths for the Treatment of Facial Acne Vulgaris
    Zeichner, Joshua A.
    Haddican, Madelaine
    Linkner, Rita V.
    Wong, Vicky
    JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (03) : 277 - 282